Clinical trial
A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in…
NCT00412737 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00412737 |
|---|---|
| Title | A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants |
| Official title | A Double-blind, Randomized, Placebo Controlled, Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Oseltamivir, Placebo |
| Enrollment | 477 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 18, 2006 |
| Last update posted | Jun 10, 2016 |
| Countries | Belgium, Canada, Czechia, Estonia, France, Germany, Hungary, Israel, Italy, Lithuania, Poland, Spain and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: